|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.080 USD | +1.89% |
|
-14.62% | -82.35% |
| 30/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 29/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 2.58Cr 2.27Cr 2.12Cr 1.95Cr 3.64Cr 247.5Cr 3.73Cr 25Cr 9.83Cr 122.48Cr 9.7Cr 9.49Cr 423.39Cr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 2.58Cr 2.27Cr 2.12Cr 1.95Cr 3.64Cr 247.5Cr 3.73Cr 25Cr 9.83Cr 122.48Cr 9.7Cr 9.49Cr 423.39Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.89% | ||
| 1 week | -14.62% | ||
| Current month | -29.41% | ||
| 1 month | -31.65% | ||
| 3 months | -62.50% | ||
| 6 months | -77.22% | ||
| Current year | -82.35% |
| 1 week | 1.03 |  | 1.25 |
| 1 month | 1.03 | | 1.95 |
| Current year | 1.03 | | 7.05 |
| 1 year | 1.03 | | 9.22 |
| 3 years | 1.03 | | 11.99 |
| 5 years | 1.03 | | 11.99 |
| 10 years | 1.03 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 01/03/2015 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 01/02/2024 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
BRD | Director/Board Member | 64 | 01/04/2015 |
Aaron Fletcher
CHM | Chairman | 46 | 01/04/2015 |
Daniel Zabrowski
BRD | Director/Board Member | 66 | 01/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/05/26 | Free | Director | 15,000 | 0.0633% | ||
| 21/05/26 | Free | Director | 15,000 | 0.0633% | ||
| 21/05/26 | Free | Director | 15,000 | 0.0633% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.89% | -14.62% | -84.05% | - | 2.58Cr | |
| -2.22% | -4.94% | +44.80% | +65.78% | 5.52TCr | |
| +2.83% | +0.48% | +28.18% | +82.59% | 5.56TCr | |
| +0.54% | +1.22% | -16.62% | -13.47% | 2.35TCr | |
| -0.97% | -3.30% | -1.79% | +383.00% | 2.24TCr | |
| -4.01% | -3.67% | +13.17% | -14.29% | 2.06TCr | |
| -1.39% | -2.94% | +26.27% | -33.69% | 1.74TCr | |
| -3.34% | -7.77% | +23.78% | +536.66% | 1.52TCr | |
| -2.09% | +0.64% | +49.78% | +178.74% | 1.39TCr | |
| -3.14% | -8.47% | +165.37% | +292.18% | 1.37TCr | |
| Average | -1.20% | -2.61% | +24.89% | +164.17% | 2.38TCr | |
| Weighted average by Cap. | -0.88% | -0.52% | +32.25% | +127.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | $1.080 | +1.89% | 59,283 |
| 28/26/28 | $1.060 | -7.83% | 2,14,395 |
| 27/26/27 | $1.150 | -2.54% | 2,26,824 |
| 24/26/24 | $1.180 | -6.35% | 93,561 |
| 23/26/23 | $1.260 | -0.40% | 1,18,313 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.080USD
Average target price
9.978USD
Spread / Average Target
+823.84%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
